Ajax Health launches pulsed-field ablation company called Cortex
Ajax Health announced today that it formed and provided funding for Cortex, a new developer of ablation technology for treating AFib.
Stay updated with breaking news from Electrographic Flow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ajax Health announced today that it formed and provided funding for Cortex, a new developer of ablation technology for treating AFib.
Share this article Share this article MENLO PARK, Calif., Jan. 7, 2021 /PRNewswire/ -- Ablacon, Inc., an Ajax Health-backed company, announced the close of a $30 million Series B financing, with Zeus Health joining as new lead investor. Ablacon also announced the addition of Dr. David Haines, Professor of Cardiovascular Medicine at Oakland University William Beaumont School of Medicine and Director of the Heart Rhythm Center at Beaumont Health, Royal Oak, MI, to the company's scientific advisory board (SAB). Ablacon plans to use the new funds to advance the company's product portfolio and ...